However, there is very little consensus on the cellular and molecular origins of prostate cancer, other than the agreement that only ~12% of PCa is genetically inherited, primarily in DNA damage repair genes, such as BRCA2 (134). The gene discussed is BRCA2; the disease is posterior cortical atrophy.